The peripheral vascular devices and equipment market size has grown steadily in recent years. It will grow from $10.29 billion in 2025 to $10.56 billion in 2026 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to increasing prevalence of peripheral artery disease, rising aging population, expansion of interventional cardiology practices, growing adoption of catheter-based therapies, increasing hospital infrastructure investments.
The peripheral vascular devices and equipment market size is expected to see strong growth in the next few years. It will grow to $13.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising use of bioresorbable materials, expansion of outpatient vascular procedures, growing focus on precision-guided interventions, increasing innovation in peripheral stent technologies. Major trends in the forecast period include increasing adoption of drug-coated vascular devices, rising use of minimally invasive endovascular procedures, growing demand for advanced atherectomy systems, expansion of image-guided peripheral interventions, enhanced focus on long-term device patency.
The rising healthcare expenditure is expected to drive the growth of the peripheral vascular devices and equipment market in the coming years. Healthcare expenditure refers to the total spending by individuals, organizations, or governments on healthcare-related goods and services over a given period. An increase in healthcare expenditure can result in higher demand for peripheral vascular devices and equipment, as healthcare systems invest in advanced medical technologies to improve the diagnosis and treatment of conditions such as peripheral artery disease, thereby enhancing patient care and clinical outcomes. For example, in April 2025, according to the Office for National Statistics (ONS), a UK-based producer of official statistics and the government’s principal data source, government-funded healthcare spending reached USD 2.91 billion (£258 billion) in 2024, representing a real-terms increase of 2.5% compared with 2023, indicating stronger investment in healthcare delivery and equipment. Therefore, rising healthcare expenditure is contributing to the expansion of the peripheral vascular devices and equipment market.
Major companies in the peripheral vascular devices and equipment market are focusing on developing innovative products to improve the treatment of peripheral artery diseases (PAD). One such advancement is the development of larger-diameter catheters, which are designed to enhance fluid administration or drainage in medical procedures, particularly in challenging vascular conditions. A notable example of this innovation is the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) catheter, launched in March 2023 by Shockwave Medical Inc. This catheter is specifically engineered to treat calcification in large peripheral vessels, such as the iliac and common femoral arteries. The Shockwave L6 catheter uses targeted lithotripsy technology to break down calcified plaque, which can impair blood flow and complicate PAD treatment. By addressing this issue, the catheter improves the procedural success rate and reduces complications compared to traditional endovascular techniques, demonstrating how advanced product development is enhancing the effectiveness of peripheral vascular treatments.
In September 2024, Boston Scientific Corporation, a leading US-based biotechnology company, acquired Silk Road Medical Inc. for $1.18 billion. This acquisition significantly strengthens Boston Scientific’s vascular technology portfolio, particularly by expanding access to Silk Road's innovative TransCarotid Artery Revascularization (TCAR) platform. The TCAR platform is designed to treat carotid artery disease, a major contributor to stroke risk. By integrating Silk Road's technology into its own, Boston Scientific aims to enhance the treatment options available to physicians and patients, ultimately improving outcomes for individuals with peripheral vascular conditions. The acquisition also allows Boston Scientific to leverage its broad commercial network to make these life-saving treatments more accessible. Silk Road Medical Inc. is recognized for its expertise in developing advanced peripheral vascular devices and equipment.
Major companies operating in the peripheral vascular devices and equipment market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cook Group, Angiomed GmbH & Co. Medizintechnik KG, Terumo Corporation, ENDOLOGIX Inc., Bolton Medical Inc., JOTEC GmbH, Clearstream Technologies, Aesculap AG, Curative Medical Devices, Lepu Medical Technology, MicroPort, Bioteque Corporation Co.Ltd., Cardinal Health, iVascular, B. Braun Group, Biosensors International Group, BIOTRONIK SE & Co., COVIDien, Volcano Corporation, AngioScore, Edwards Lifesciences Corporation, Cordis Corporation, Koninklijke Philips N.V., Nipro Corporation, Bluesail Medical Co. Ltd, Rex Medical, Teleflex Incorporated, Penumbra Inc., Lombard Medical Technologies PLC, W.L. Gore & Associates Inc., Merit Medical Systems Inc., Vascular Solutions Inc., LeMaitre Vascular Inc., Spectranetics Corporation.
North America was the largest region in global peripheral vascular devices and equipment market in 2025. Western Europe was the second-largest region in global peripheral vascular devices and equipment market. The regions covered in the peripheral vascular devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral vascular devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the peripheral vascular devices and equipment market by increasing costs of imported specialty metals, polymers, coatings, imaging components, and precision-manufactured catheters and stents. Hospitals and clinics in North America and Europe are most affected due to dependence on imported high-value vascular devices, while Asia-Pacific faces higher costs for export-oriented device manufacturing. These tariffs are raising procedure costs and impacting inventory planning. However, they are also encouraging regional manufacturing, local sourcing of medical-grade materials, and expanded domestic production of peripheral vascular devices.
The peripheral vascular devices and equipment market research report is one of a series of new reports that provides peripheral vascular devices and equipment market statistics, including peripheral vascular devices and equipment industry global market size, regional shares, competitors with a peripheral vascular devices and equipment market share, detailed peripheral vascular devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vascular devices and equipment industry. This peripheral vascular devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peripheral vascular devices and equipment play a crucial role in the management of peripheral vascular diseases, which are characterized by the gradual and progressive impairment of blood circulation in blood vessels located outside the heart and brain, encompassing both arteries and veins. These conditions typically result from blockages, narrowing, or spasms within these vessels.
The primary categories of peripheral vascular devices and equipment include peripheral vascular stents, percutaneous transluminal angioplasty balloons, catheters, PTA guide wires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. Catheters, for instance, are tubular medical devices designed for insertion into canals, vessels, passageways, or body cavities to facilitate the injection or withdrawal of fluids or to maintain the patency of a passage. These devices find application in the treatment of damaged peripheral blood vessels and the management of blockages in peripheral blood vessels, ultimately enhancing blood circulation and supporting patient health. Various healthcare settings, including hospitals and clinics, utilize peripheral vascular devices and equipment to address these medical conditions.
The peripheral vascular devices and equipment market consist of sales of peripheral vascular stents, percutaneous transluminal angioplasty balloons, PTA drug-eluting balloons, embolic protection devices, inferior vena cava filters, Aortic stent-grafts, synthetic surgical drafts, and peripheral guide wires. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The peripheral vascular devices and equipment market size is expected to see strong growth in the next few years. It will grow to $13.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising use of bioresorbable materials, expansion of outpatient vascular procedures, growing focus on precision-guided interventions, increasing innovation in peripheral stent technologies. Major trends in the forecast period include increasing adoption of drug-coated vascular devices, rising use of minimally invasive endovascular procedures, growing demand for advanced atherectomy systems, expansion of image-guided peripheral interventions, enhanced focus on long-term device patency.
The rising healthcare expenditure is expected to drive the growth of the peripheral vascular devices and equipment market in the coming years. Healthcare expenditure refers to the total spending by individuals, organizations, or governments on healthcare-related goods and services over a given period. An increase in healthcare expenditure can result in higher demand for peripheral vascular devices and equipment, as healthcare systems invest in advanced medical technologies to improve the diagnosis and treatment of conditions such as peripheral artery disease, thereby enhancing patient care and clinical outcomes. For example, in April 2025, according to the Office for National Statistics (ONS), a UK-based producer of official statistics and the government’s principal data source, government-funded healthcare spending reached USD 2.91 billion (£258 billion) in 2024, representing a real-terms increase of 2.5% compared with 2023, indicating stronger investment in healthcare delivery and equipment. Therefore, rising healthcare expenditure is contributing to the expansion of the peripheral vascular devices and equipment market.
Major companies in the peripheral vascular devices and equipment market are focusing on developing innovative products to improve the treatment of peripheral artery diseases (PAD). One such advancement is the development of larger-diameter catheters, which are designed to enhance fluid administration or drainage in medical procedures, particularly in challenging vascular conditions. A notable example of this innovation is the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) catheter, launched in March 2023 by Shockwave Medical Inc. This catheter is specifically engineered to treat calcification in large peripheral vessels, such as the iliac and common femoral arteries. The Shockwave L6 catheter uses targeted lithotripsy technology to break down calcified plaque, which can impair blood flow and complicate PAD treatment. By addressing this issue, the catheter improves the procedural success rate and reduces complications compared to traditional endovascular techniques, demonstrating how advanced product development is enhancing the effectiveness of peripheral vascular treatments.
In September 2024, Boston Scientific Corporation, a leading US-based biotechnology company, acquired Silk Road Medical Inc. for $1.18 billion. This acquisition significantly strengthens Boston Scientific’s vascular technology portfolio, particularly by expanding access to Silk Road's innovative TransCarotid Artery Revascularization (TCAR) platform. The TCAR platform is designed to treat carotid artery disease, a major contributor to stroke risk. By integrating Silk Road's technology into its own, Boston Scientific aims to enhance the treatment options available to physicians and patients, ultimately improving outcomes for individuals with peripheral vascular conditions. The acquisition also allows Boston Scientific to leverage its broad commercial network to make these life-saving treatments more accessible. Silk Road Medical Inc. is recognized for its expertise in developing advanced peripheral vascular devices and equipment.
Major companies operating in the peripheral vascular devices and equipment market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cook Group, Angiomed GmbH & Co. Medizintechnik KG, Terumo Corporation, ENDOLOGIX Inc., Bolton Medical Inc., JOTEC GmbH, Clearstream Technologies, Aesculap AG, Curative Medical Devices, Lepu Medical Technology, MicroPort, Bioteque Corporation Co.Ltd., Cardinal Health, iVascular, B. Braun Group, Biosensors International Group, BIOTRONIK SE & Co., COVIDien, Volcano Corporation, AngioScore, Edwards Lifesciences Corporation, Cordis Corporation, Koninklijke Philips N.V., Nipro Corporation, Bluesail Medical Co. Ltd, Rex Medical, Teleflex Incorporated, Penumbra Inc., Lombard Medical Technologies PLC, W.L. Gore & Associates Inc., Merit Medical Systems Inc., Vascular Solutions Inc., LeMaitre Vascular Inc., Spectranetics Corporation.
North America was the largest region in global peripheral vascular devices and equipment market in 2025. Western Europe was the second-largest region in global peripheral vascular devices and equipment market. The regions covered in the peripheral vascular devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral vascular devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the peripheral vascular devices and equipment market by increasing costs of imported specialty metals, polymers, coatings, imaging components, and precision-manufactured catheters and stents. Hospitals and clinics in North America and Europe are most affected due to dependence on imported high-value vascular devices, while Asia-Pacific faces higher costs for export-oriented device manufacturing. These tariffs are raising procedure costs and impacting inventory planning. However, they are also encouraging regional manufacturing, local sourcing of medical-grade materials, and expanded domestic production of peripheral vascular devices.
The peripheral vascular devices and equipment market research report is one of a series of new reports that provides peripheral vascular devices and equipment market statistics, including peripheral vascular devices and equipment industry global market size, regional shares, competitors with a peripheral vascular devices and equipment market share, detailed peripheral vascular devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vascular devices and equipment industry. This peripheral vascular devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peripheral vascular devices and equipment play a crucial role in the management of peripheral vascular diseases, which are characterized by the gradual and progressive impairment of blood circulation in blood vessels located outside the heart and brain, encompassing both arteries and veins. These conditions typically result from blockages, narrowing, or spasms within these vessels.
The primary categories of peripheral vascular devices and equipment include peripheral vascular stents, percutaneous transluminal angioplasty balloons, catheters, PTA guide wires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. Catheters, for instance, are tubular medical devices designed for insertion into canals, vessels, passageways, or body cavities to facilitate the injection or withdrawal of fluids or to maintain the patency of a passage. These devices find application in the treatment of damaged peripheral blood vessels and the management of blockages in peripheral blood vessels, ultimately enhancing blood circulation and supporting patient health. Various healthcare settings, including hospitals and clinics, utilize peripheral vascular devices and equipment to address these medical conditions.
The peripheral vascular devices and equipment market consist of sales of peripheral vascular stents, percutaneous transluminal angioplasty balloons, PTA drug-eluting balloons, embolic protection devices, inferior vena cava filters, Aortic stent-grafts, synthetic surgical drafts, and peripheral guide wires. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Peripheral Vascular Devices and Equipment Market Characteristics
3. Peripheral Vascular Devices and Equipment Market Supply Chain Analysis
4. Global Peripheral Vascular Devices and Equipment Market Trends and Strategies
5. Peripheral Vascular Devices and Equipment Market Analysis of End Use Industries
7. Global Peripheral Vascular Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Peripheral Vascular Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Peripheral Vascular Devices and Equipment Market Segmentation
10. Peripheral Vascular Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Peripheral Vascular Devices and Equipment Market
12. China Peripheral Vascular Devices and Equipment Market
13. India Peripheral Vascular Devices and Equipment Market
14. Japan Peripheral Vascular Devices and Equipment Market
15. Australia Peripheral Vascular Devices and Equipment Market
16. Indonesia Peripheral Vascular Devices and Equipment Market
17. South Korea Peripheral Vascular Devices and Equipment Market
18. Bangladesh Peripheral Vascular Devices and Equipment Market
19. Thailand Peripheral Vascular Devices and Equipment Market
20. Vietnam Peripheral Vascular Devices and Equipment Market
21. Malaysia Peripheral Vascular Devices and Equipment Market
22. Singapore Peripheral Vascular Devices and Equipment Market
23. Philippines Peripheral Vascular Devices and Equipment Market
24. Hong Kong Peripheral Vascular Devices and Equipment Market
25. New Zealand Peripheral Vascular Devices and Equipment Market
26. Taiwan Peripheral Vascular Devices and Equipment Market
27. South East Asia Peripheral Vascular Devices and Equipment Market
28. Western Europe Peripheral Vascular Devices and Equipment Market
29. UK Peripheral Vascular Devices and Equipment Market
30. Germany Peripheral Vascular Devices and Equipment Market
31. France Peripheral Vascular Devices and Equipment Market
32. Italy Peripheral Vascular Devices and Equipment Market
33. Spain Peripheral Vascular Devices and Equipment Market
34. Austria Peripheral Vascular Devices and Equipment Market
35. Belgium Peripheral Vascular Devices and Equipment Market
36. Denmark Peripheral Vascular Devices and Equipment Market
37. Finland Peripheral Vascular Devices and Equipment Market
38. Ireland Peripheral Vascular Devices and Equipment Market
39. Netherlands Peripheral Vascular Devices and Equipment Market
40. Norway Peripheral Vascular Devices and Equipment Market
41. Portugal Peripheral Vascular Devices and Equipment Market
42. Sweden Peripheral Vascular Devices and Equipment Market
42. Switzerland Peripheral Vascular Devices and Equipment Market
43. Eastern Europe Peripheral Vascular Devices and Equipment Market
44. Russia Peripheral Vascular Devices and Equipment Market
45. Czech Republic Peripheral Vascular Devices and Equipment Market
46. Poland Peripheral Vascular Devices and Equipment Market
47. Romania Peripheral Vascular Devices and Equipment Market
48. Ukraine Peripheral Vascular Devices and Equipment Market
49. North America Peripheral Vascular Devices and Equipment Market
50. USA Peripheral Vascular Devices and Equipment Market
51. Canada Peripheral Vascular Devices and Equipment Market
52. Mexico Peripheral Vascular Devices and Equipment Market
53. South America Peripheral Vascular Devices and Equipment Market
54. Brazil Peripheral Vascular Devices and Equipment Market
55. Chile Peripheral Vascular Devices and Equipment Market
56. Argentina Peripheral Vascular Devices and Equipment Market
57. Colombia Peripheral Vascular Devices and Equipment Market
58. Peru Peripheral Vascular Devices and Equipment Market
59. Middle East Peripheral Vascular Devices and Equipment Market
60. Saudi Arabia Peripheral Vascular Devices and Equipment Market
61. Israel Peripheral Vascular Devices and Equipment Market
62. Iran Peripheral Vascular Devices and Equipment Market
63. Turkey Peripheral Vascular Devices and Equipment Market
64. United Arab Emirates Peripheral Vascular Devices and Equipment Market
65. Africa Peripheral Vascular Devices and Equipment Market
66. Egypt Peripheral Vascular Devices and Equipment Market
67. Nigeria Peripheral Vascular Devices and Equipment Market
68. South Africa Peripheral Vascular Devices and Equipment Market
70. Peripheral Vascular Devices and Equipment Market Competitive Landscape and Company Profiles
71. Peripheral Vascular Devices and Equipment Market Other Major and Innovative Companies
74. Peripheral Vascular Devices and Equipment Market High Potential Countries, Segments and Strategies
75. Appendix
Executive Summary
Peripheral Vascular Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses peripheral vascular devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for peripheral vascular devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral vascular devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Peripheral vascular stents; Percutaneous transluminal angioplasty balloons; Catheters; PTA guide wires; Atherectomy devices; Chronic total acclusion devices; Aortic stents; Synthetic surgical grafts; Embolic protection devices; Inferior vena cava filters2) By Application: Treatment of Peripheral Blood Vessels Damaged; Treatment of Peripheral Blood Vessels Blockage
3) By End User: Hospital applications; Clinic applications
Subsegments:
1) By Peripheral Vascular Stents: Balloon-expandable Stents; Self-expanding Stents2) By Percutaneous Transluminal Angioplasty Balloons: Drug-coated Balloons; Non-drug-Coated Balloons
3) By Catheters: Diagnostic Catheters; Therapeutic Catheters
4) By PTA Guide Wires: Hydrophilic Guide Wires; Non-hydrophilic Guide Wires
5) By Atherectomy Devices: Rotational Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices; Directional Atherectomy Devices
6) By Chronic Total Occlusion Devices: CTO crossing devices; CTO re-entry devices
7) By Aortic Stents: Self-expanding Aortic Stents; Balloon-expandable Aortic Stents
8) By Synthetic Surgical Grafts: Polyester Grafts; Polytetrafluoroethylene (PTFE) Grafts; Dacron Grafts
9) By Embolic Protection Devices: Distal Protection Devices; Proximal Protection Devices
10) By Inferior Vena Cava Filters: Permanent Filters; Retrievable Filters
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Cook Group; Angiomed GmbH & Co. Medizintechnik KG; Terumo Corporation; ENDOLOGIX Inc.; Bolton Medical Inc.; JOTEC GmbH; Clearstream Technologies; Aesculap AG; Curative Medical Devices; Lepu Medical Technology; MicroPort; Bioteque Corporation Co.Ltd.; Cardinal Health; iVascular; B. Braun Group; Biosensors International Group; BIOTRONIK SE & Co.; COVIDien; Volcano Corporation; AngioScore; Edwards Lifesciences Corporation; Cordis Corporation; Koninklijke Philips N.V.; Nipro Corporation; Bluesail Medical Co. Ltd; Rex Medical; Teleflex Incorporated; Penumbra Inc.; Lombard Medical Technologies PLC; W.L. Gore & Associates Inc.; Merit Medical Systems Inc.; Vascular Solutions Inc.; LeMaitre Vascular Inc.; Spectranetics Corporation
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Peripheral Vascular Devices and Equipment market report include:- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cook Group
- Angiomed GmbH & Co. Medizintechnik KG
- Terumo Corporation
- ENDOLOGIX Inc.
- Bolton Medical Inc.
- JOTEC GmbH
- Clearstream Technologies
- Aesculap AG
- Curative Medical Devices
- Lepu Medical Technology
- MicroPort
- Bioteque Corporation Co.Ltd.
- Cardinal Health
- iVascular
- B. Braun Group
- Biosensors International Group
- BIOTRONIK SE & Co.
- COVIDien
- Volcano Corporation
- AngioScore
- Edwards Lifesciences Corporation
- Cordis Corporation
- Koninklijke Philips N.V.
- Nipro Corporation
- Bluesail Medical Co. Ltd
- Rex Medical
- Teleflex Incorporated
- Penumbra Inc.
- Lombard Medical Technologies PLC
- W.L. Gore & Associates Inc.
- Merit Medical Systems Inc.
- Vascular Solutions Inc.
- LeMaitre Vascular Inc.
- Spectranetics Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.56 Billion |
| Forecasted Market Value ( USD | $ 13.15 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 38 |
